Galectin Therapeutics (GALT) to Resume Trading at 4:45PM ET

September 27, 2016 4:24 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Galectin Therapeutics (NASDAQ: GALT) to resume trading at 4:45PM following study failure.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk, Trading Halts

Add Your Comment